Antibiotic and antiseptic resistance: impact on public health
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Antibiotic resistance was recognized soon after the discovery of antibiotics. During the past 50 years the rise in the frequency of resistance, particularly to multiple drugs, has thwarted treatment of patients in the hospital and the community. 1 Bacteria have continued to respond to human attempts to keep them in check. Methicillin was developed and introduced in the 1960s to circumvent inactivation by the common beta-lactamases that caused penicillin resistance. But methicillin-resistant Staphylococcus aureus (MRSA) emerged soon after to combat the beta-lactamase-resistant penicillin analog. More recently vancomycin, the antibiotic of choice for treating multidrug-resistant MRSA, has confronted resistant strains in Japan, the United States and Europe. 2 In England MRSA with heterogeneous resistance to vancomycin has been implicated in the treatment failure of 12 out of 14 patients who underwent orthopedic procedures. 3 Heterogeneous resistance to vancomycin implies that only one in a million progeny of the isolates taken from the patients showed intermediate resistance to vancomycin. Some hospital-acquired vancomycin-resistant enterococcal infections are resistant to all current antibiotics. 4 Other problem strains in the hospital include Klebsiella and Enterobacter and the opportunistic pathogens Pseudomonas aeruginosa and Acinetobacter baumanii. In the community a number of different bacteria that cause relatively common diseases have acquired multidrug resistance. These include strains of Streptococcus pneumoniae, which cause otitis media, pneumonia and meningitis. This finding is at least partially linked to misuse and overuse of antibiotics for viral-caused ear infections and upper respiratory symptoms. Although two-thirds of all ear infections are bacterial, 5 85% will resolve with no antibiotic treatment, yet antibiotics are prescribed for almost every child in the United States. 5 Because of widespread resistance, penicillin can no longer be relied on for treating meningitis caused by S. pneumoniae. A combination of drugs, i.e. vancomycin plus a cephalosporin, is recommended for the treatment of this community-acquired infection. 6 Neisseria gonorrhoeae, previously easily treated with a single penicillin injection, has become so frequently resistant to this antibiotic that alternative drugs have been required. Today resistance to tetracyclines and fluoroquinolones has developed in N. gonorrhoeae as well, making a third generation cephalosporin the preferred antibiotic therapy. There are no other single dose drug therapy options remaining to treat this community-acquired disease when cephalosporin resistance emerges. The history of Neisseria treatment illustrates an important phenomenon of drug resistance. With time there is often an accumulation of resistance to many drugs in the same organism. 1 Another example is Streptococcus pyogenes, the “flesh-eating bacteria” and the cause of strep throat. Historically this organism remained susceptible to all drugs. Its present day resistance to erythromycin and tetracycline reveals that with continued antibiotic use over time, resistance, even multidrug resistance, will emerge. 7 Likewise Escherichia coli and other enteric organisms such as Salmonella have also acquired multidrug resistance. Some Salmonella strains, like Salmonella typhimurium DT104, are resistant to five different antibiotics; therefore fluoroquinolones have become the only remaining effective treatment. When quinolones were first introduced, it was thought that bacteria resistant to quinolones would not become a problem because of the high susceptibility of the bacterium and the seemingly low frequency of resistance. This hope has been dispelled. Resistance to fluoroquinolones has appeared and patients are failing treatment. 8 This resistance requires at least two chromosomal mutations to be clinically relevant. Today in certain parts of Asia, 50 to 60% of E. coli may be fluoroquinolone-resistant. Simplistically antibiotic resistance is a natural expression of evolution and bacterial genetics. The more a particular antibiotic is used, the greater is the chance of developing a resistance problem. Over time multidrug resistance can be acquired through stepwise accumulation of mutations or by acquisition of resistance genes from other bacteria. 9 DNA plasmids containing drug resistance genes can be exchanged among bacteria by a process of cell-to-cell association called conjugation. In this way, multidrug resistance can be spread among different bacterial types. Transposons, which are smaller pieces of DNA, can transpose (move) between chromosomes and plasmids in a cell. Through a process called transformation or through bacterial viruses called bacteriophages, bacteria can pick up foreign DNA bearing new genes, including resistance genes. These genetic exchanges constantly occur among bacteria and are usually harmless, but the exchange of resistance genes, aided by antibiotic selection,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 2×
“More recently vancomycin, the antibiotic of choice for treating multidrug-resistant MRSA, has confronted resistant strains in Japan, the United States and Europe.(2) In England MRSA with heterogeneous resistance to vancomycin has been implicated in the treatment failure of 12 out of 14 patients who underwent orthopedi…”
Background
Cited by
Bacterial resistance to silver in wound care
Percival, S. L., Bowler, P. G., & Russell, D. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.11.014 · Cited by 867
Buffet-Bataillon, S., Tattevin, P., Bonnaure-Mallet, M., & Jolivet-Gougeon, A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.01.011 · Cited by 601
Cock, I., Cheesman, M., Ilanko, A., & Blonk, B. (2017) · Pharmacognosy Reviews · doi:10.4103/phrev.phrev_21_17 · Cited by 550
Factors impacting on the problem of antibiotic resistance
Levy, S. B. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.25 · Cited by 547
Self-citationCmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni
Lin, J., Michel, L. O., & Zhang, Q. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2124-2131.2002 · Cited by 528
Metadata
- Authors
- LEVY, S. B.
- Venue
- The Pediatric Infectious Disease Journal
- Published
- 2000-10
- Volume
- 19
- Issue
- Supplement
- Pages
- S120-S122
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W2076928573
- Cited by
- 133
- References
- 1
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibiotic and antiseptic resistance: impact on public health. https://app.cochat.ai/papers/10.1097/00006454-200010001-00008
- The paper
- LEVY, S. B. (2000). Antibiotic and antiseptic resistance: impact on public health. The Pediatric Infectious Disease Journal. https://doi.org/10.1097/00006454-200010001-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.